InspectifAI is the standalone, machine-agnostic software solution that orchestrates, manages and executes the scalable usage and deployment of artificial intelligence in visual inspection with the mission to improve drug & patient safety. InspectifAI is a spin-off of the Körber Group, an international technology group that has around 10,000 employees all over the world. As a joint venture of the two business areas Digital and Pharma, we are combining necessary competencies of both worlds: Regulatory expertise, visual inspection and validation know-how with data science, software development and design competencies. We believe in the power of data and their ability to radically redesign and optimize visual inspection in the pharmaceutical industry. By leveraging insights and learnings among diverse machine platforms, we create synergy, network and scaling effects - making the best out of AI for visual inspection. We provide an end-to-end AI solution to improve detection accuracy, minimize false-eject-rates, monitor inspection results and enable the machine-agnostic transfer of AI-models. As drug & patient safety requires the best technological approach in combination with reliable, compliant and trustworthy execution, we accompany our customers from the initial consulting to data acquisition, model training, model implementation and final validation. With our years of significant experience in Pharma, we know the boundary conditions of the pharmaceutical industry and understand the needs and requirements of our customers.